REG - Inspiration Health - Appointment of Joint Broker

Inspiration HealthcareAnnouncement

03/02/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260203:nRSC3953Ra&default-theme=true

RNS Number : 3953R  Inspiration Healthcare Group PLC  03 February 2026

3 February 2026

 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Appointment of Joint Broker

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company, announces the appointment of Cavendish Capital Markets Limited
("Cavendish") as joint broker to the Company with immediate effect. Cavendish
will work alongside Panmure Liberum, the Group's existing nominated adviser
and corporate broker.

 

 Enquiries:

 

 Inspiration Healthcare Group plc                                    Tel: +44 (0)330
                                     175 0000
 Raffi Stepanian, Chief Executive Officer
 Alan Olby, Chief Financial Officer

 Panmure Liberum (Nominated Adviser & Broker)                                                                                           Tel: +44 (0)20
                                                                                                        3100 2000
 Will Goode

 Emma Earl
 Mark Rogers

 Cavendish Capital Markets (Joint Broker)                   Tel: + 44 (0)20 7220 0500
 Giles Balleny / Joe Smith
 Nigel Birks
 Harriet Ward

 Walbrook PR Ltd (Media & IR)        Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
                                     (mailto:inspirationhealthcare@walbrookpr.com)
 Anna Dunphy                         Mob: +44 (0) 7876 741 001
 Rachel Broad                        Mob: +44 (0) 7747 515 393

 

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets
pioneering medical technology. Based in the UK, the Company specialises in
neonatal intensive care medical devices, which are addressing a critical need
to help to save the lives and improve the outcomes of patients, starting with
the very first breaths of life.

 

 The Company has a broad portfolio of its own products and complementary
distributed products, for use in neonatal intensive care designed to support
even the most premature babies throughout their hospital stay. Its own branded
products range from highly sophisticated capital equipment such as ventilators
for life support through to single-use disposables.

 

 The Company sells its products directly to hospitals and healthcare
providers in the UK and Ireland, where it also distributes a range of advanced
medical technologies for infusion therapy.  In the rest of the world the
Company has an established network of distribution partners around the world
giving access to more than 75 countries.

 

 The Company operates in the UK from its world-class Manufacturing and
Technology Centre in Croydon, South London and in the USA from its facility in
Melbourne, Florida.

 

 Further information on Inspiration Healthcare can be found
at www.inspirationhealthcaregroup.com
(http://www.inspirationhealthcaregroup.com/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPDLLFBQLLBBBQ



            Copyright 2019 Regulatory News Service, all rights reserved